BRISTOL INVESTMENT FUND LTD - 29 May 2025 SCHEDULE 13G/A Report for GT Biopharma, Inc. Common Stock (GTBP)

Filing Manager: BRISTOL INVESTMENT FUND LTD
Reporting Manager: Bristol Investment Fund, Ltd.
Security: GT Biopharma, Inc. Common Stock
Symbol: GTBP
Shares outstanding: 3,148,458 shares
Disclosed Ownership: 74,524 shares
Ownership: 2.4%
Form type: SCHEDULE 13G/A
Filing time: 02 Jun 2025, 19:46:09 UTC
Date of event: 29 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Bristol Investment Fund, Ltd.	2.4%	74,524	74,524	0	/s/ Paul Kessler	Paul Kessler, Director
Bristol Capital, LLC	4.8%	0	150,000	0	/s/ Paul Kessler	Paul Kessler, Manager, Bristol Capital, LLC